Selected article for: "direct exposure and exposure history"

Author: Han, Xuejiao; Li, Xuemei; Xiao, Yinan; Yang, Ruoning; Wang, Yang; Wei, Xiawei
Title: Distinct Characteristics of COVID-19 Infection in Children
  • Cord-id: n57bb147
  • Document date: 2021_3_4
  • ID: n57bb147
    Snippet: SARS-CoV-2, a member of the family coronaviridae, has triggered a lethal pandemic termed coronavirus disease 2019 (COVID-19). Pediatric patients, mainly from families with a cluster of infection or a history of exposure to epidemic areas, get infected via direct contacts or air-borne droplets. Children (aged below 18 years) are susceptible to COVID-19, with an average incubation period of about 6.5 days. Most cases present asymptomatic or common cold symptoms such as fever, cough, and myalgia or
    Document: SARS-CoV-2, a member of the family coronaviridae, has triggered a lethal pandemic termed coronavirus disease 2019 (COVID-19). Pediatric patients, mainly from families with a cluster of infection or a history of exposure to epidemic areas, get infected via direct contacts or air-borne droplets. Children (aged below 18 years) are susceptible to COVID-19, with an average incubation period of about 6.5 days. Most cases present asymptomatic or common cold symptoms such as fever, cough, and myalgia or fatigue, which is milder than adult patients. Besides, most abnormal laboratory and radiologic findings in children with COVID-19 are non-specific. Since no specific chemotherapeutic agents have been approved for children, timely preventive methods could effectively forestall the transmission of SARS-CoV-2. To date, mostly studied cases have been adults with COVID-19, whereas data on pediatrics patients remain poorly defined. We herein conducted a literature review for papers published in PubMed and medRxiv (preprints) between December 2019 and December 2020 that reported on pediatrics patients (aged below 18 years) with a confirmed COVID-19 diagnosis. In this review, we summarized and discussed the pathogenesis, epidemiology, and clinical management of COVID-19 in pediatrics patients to improve our understanding of this new disease in children.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • abdominal pain and acute phase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • abdominal pain diarrhea and abnormal chest: 1
    • abdominal pain diarrhea and acute ards respiratory distress syndrome: 1
    • abdominal pain diarrhea and acute phase: 1, 2, 3
    • abdominal pain diarrhea vomiting and abnormal chest: 1
    • abdominal pain diarrhea vomiting and acute phase: 1, 2
    • abdominal pain diarrhea vomiting nausea and acute phase: 1, 2
    • abnormal chest and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • abnormal chest and acute phase: 1, 2, 3, 4
    • abnormal chest imaging and acute ards respiratory distress syndrome: 1
    • abnormal chest imaging and acute phase: 1, 2
    • absent mild and acute ards respiratory distress syndrome: 1
    • absent mild and acute phase: 1
    • acute ards respiratory distress syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute ards respiratory distress syndrome and adaptive innate immunity: 1, 2, 3, 4, 5
    • acute phase and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute phase and adaptive innate immunity: 1, 2, 3